Global Lung Cancer Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 116 pages | ID: G907922B477GEN
GlobalInfoResearch

Abstracts

Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as primary lung cancers, are carcinomas. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains.

SCOPE OF THE REPORT:

This report studies the Lung Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Lung Cancer market by product type and applications/end industries.
Lung cancer is the most common cause of cancer-related death in men and second most common in women after breast cancer. The most common age at diagnosis is 70 years. Overall, 17.4% of people in the United States diagnosed with lung cancer survive five years after the diagnosis, while outcomes on average are worse in the developing world.
The global Lung Cancer market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Lung Cancer.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Roche
• Novartis
• Pfizer
• Merck
• Bristol-Myers Squibb
• Eli Lilly And Company
• Sanof

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• SCLC Lung Cancer
• NSCLC Lung Cancer

Market Segment by Applications, can be divided into

• Hospital & Clinics
• Cancer Research Centers
• Laboratories

Contents

1 LUNG CANCER MARKET OVERVIEW

1.1 Product Overview and Scope of Lung Cancer
1.2 Classification of Lung Cancer by Types
  1.2.1 Global Lung Cancer Revenue Comparison by Types (2017-2023)
  1.2.2 Global Lung Cancer Revenue Market Share by Types in 2017
  1.2.3 SCLC Lung Cancer
  1.2.4 NSCLC Lung Cancer
1.3 Global Lung Cancer Market by Application
  1.3.1 Global Lung Cancer Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospital & Clinics
  1.3.3 Cancer Research Centers
  1.3.4 Laboratories
1.4 Global Lung Cancer Market by Regions
  1.4.1 Global Lung Cancer Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Lung Cancer Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Lung Cancer Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lung Cancer Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Lung Cancer Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lung Cancer Status and Prospect (2013-2023)
1.5 Global Market Size of Lung Cancer (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Roche
  2.1.1 Business Overview
  2.1.2 Lung Cancer Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Roche Lung Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
  2.2.1 Business Overview
  2.2.2 Lung Cancer Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Novartis Lung Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
  2.3.1 Business Overview
  2.3.2 Lung Cancer Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Pfizer Lung Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
  2.4.1 Business Overview
  2.4.2 Lung Cancer Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Merck Lung Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bristol-Myers Squibb
  2.5.1 Business Overview
  2.5.2 Lung Cancer Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Bristol-Myers Squibb Lung Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly And Company
  2.6.1 Business Overview
  2.6.2 Lung Cancer Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Eli Lilly And Company Lung Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sanof
  2.7.1 Business Overview
  2.7.2 Lung Cancer Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Sanof Lung Cancer Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL LUNG CANCER MARKET COMPETITION, BY PLAYERS

3.1 Global Lung Cancer Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Lung Cancer Players Market Share
  3.2.2 Top 10 Lung Cancer Players Market Share
3.3 Market Competition Trend

4 GLOBAL LUNG CANCER MARKET SIZE BY REGIONS

4.1 Global Lung Cancer Revenue and Market Share by Regions
4.2 North America Lung Cancer Revenue and Growth Rate (2013-2018)
4.3 Europe Lung Cancer Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Lung Cancer Revenue and Growth Rate (2013-2018)
4.5 South America Lung Cancer Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Lung Cancer Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA LUNG CANCER REVENUE BY COUNTRIES

5.1 North America Lung Cancer Revenue by Countries (2013-2018)
5.2 USA Lung Cancer Revenue and Growth Rate (2013-2018)
5.3 Canada Lung Cancer Revenue and Growth Rate (2013-2018)
5.4 Mexico Lung Cancer Revenue and Growth Rate (2013-2018)

6 EUROPE LUNG CANCER REVENUE BY COUNTRIES

6.1 Europe Lung Cancer Revenue by Countries (2013-2018)
6.2 Germany Lung Cancer Revenue and Growth Rate (2013-2018)
6.3 UK Lung Cancer Revenue and Growth Rate (2013-2018)
6.4 France Lung Cancer Revenue and Growth Rate (2013-2018)
6.5 Russia Lung Cancer Revenue and Growth Rate (2013-2018)
6.6 Italy Lung Cancer Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC LUNG CANCER REVENUE BY COUNTRIES

7.1 Asia-Pacific Lung Cancer Revenue by Countries (2013-2018)
7.2 China Lung Cancer Revenue and Growth Rate (2013-2018)
7.3 Japan Lung Cancer Revenue and Growth Rate (2013-2018)
7.4 Korea Lung Cancer Revenue and Growth Rate (2013-2018)
7.5 India Lung Cancer Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Lung Cancer Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA LUNG CANCER REVENUE BY COUNTRIES

8.1 South America Lung Cancer Revenue by Countries (2013-2018)
8.2 Brazil Lung Cancer Revenue and Growth Rate (2013-2018)
8.3 Argentina Lung Cancer Revenue and Growth Rate (2013-2018)
8.4 Colombia Lung Cancer Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE LUNG CANCER BY COUNTRIES

9.1 Middle East and Africa Lung Cancer Revenue by Countries (2013-2018)
9.2 Saudi Arabia Lung Cancer Revenue and Growth Rate (2013-2018)
9.3 UAE Lung Cancer Revenue and Growth Rate (2013-2018)
9.4 Egypt Lung Cancer Revenue and Growth Rate (2013-2018)
9.5 Nigeria Lung Cancer Revenue and Growth Rate (2013-2018)
9.6 South Africa Lung Cancer Revenue and Growth Rate (2013-2018)

10 GLOBAL LUNG CANCER MARKET SEGMENT BY TYPE

10.1 Global Lung Cancer Revenue and Market Share by Type (2013-2018)
10.2 Global Lung Cancer Market Forecast by Type (2018-2023)
10.3 SCLC Lung Cancer Revenue Growth Rate (2013-2023)
10.4 NSCLC Lung Cancer Revenue Growth Rate (2013-2023)

11 GLOBAL LUNG CANCER MARKET SEGMENT BY APPLICATION

11.1 Global Lung Cancer Revenue Market Share by Application (2013-2018)
11.2 Lung Cancer Market Forecast by Application (2018-2023)
11.3 Hospital & Clinics Revenue Growth (2013-2018)
11.4 Cancer Research Centers Revenue Growth (2013-2018)
11.5 Laboratories Revenue Growth (2013-2018)

12 GLOBAL LUNG CANCER MARKET SIZE FORECAST (2018-2023)

12.1 Global Lung Cancer Market Size Forecast (2018-2023)
12.2 Global Lung Cancer Market Forecast by Regions (2018-2023)
12.3 North America Lung Cancer Revenue Market Forecast (2018-2023)
12.4 Europe Lung Cancer Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Lung Cancer Revenue Market Forecast (2018-2023)
12.6 South America Lung Cancer Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Lung Cancer Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Lung Cancer Picture
Table Product Specifications of Lung Cancer
Table Global Lung Cancer and Revenue (Million USD) Market Split by Product Type
Figure Global Lung Cancer Revenue Market Share by Types in 2017
Figure SCLC Lung Cancer? Picture
Figure NSCLC Lung Cancer Picture
Table Global Lung Cancer Revenue (Million USD) by Application (2013-2023)
Figure Lung Cancer Revenue Market Share by Applications in 2017
Figure Hospital & Clinics Picture
Figure Cancer Research Centers Picture
Figure Laboratories Picture
Table Global Market Lung Cancer Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Lung Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Lung Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Lung Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Lung Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Lung Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Lung Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Lung Cancer Type and Applications
Table Roche Lung Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Lung Cancer Type and Applications
Table Novartis Lung Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Lung Cancer Type and Applications
Table Pfizer Lung Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Lung Cancer Type and Applications
Table Merck Lung Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Lung Cancer Type and Applications
Table Bristol-Myers Squibb Lung Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly And Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly And Company Lung Cancer Type and Applications
Table Eli Lilly And Company Lung Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Sanof Basic Information, Manufacturing Base and Competitors
Table Sanof Lung Cancer Type and Applications
Table Sanof Lung Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Global Lung Cancer Revenue (Million USD) by Players (2013-2018)
Table Global Lung Cancer Revenue Share by Players (2013-2018)
Figure Global Lung Cancer Revenue Share by Players in 2016
Figure Global Lung Cancer Revenue Share by Players in 2017
Figure Global Top 5 Players Lung Cancer Revenue Market Share in 2017
Figure Global Top 10 Players Lung Cancer Revenue Market Share in 2017
Figure Global Lung Cancer Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Lung Cancer Revenue (Million USD) by Regions (2013-2018)
Table Global Lung Cancer Revenue Market Share by Regions (2013-2018)
Figure Global Lung Cancer Revenue Market Share by Regions (2013-2018)
Figure Global Lung Cancer Revenue Market Share by Regions in 2017
Figure North America Lung Cancer Revenue and Growth Rate (2013-2018)
Figure Europe Lung Cancer Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Lung Cancer Revenue and Growth Rate (2013-2018)
Figure South America Lung Cancer Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Lung Cancer Revenue and Growth Rate (2013-2018)
Table North America Lung Cancer Revenue by Countries (2013-2018)
Table North America Lung Cancer Revenue Market Share by Countries (2013-2018)
Figure North America Lung Cancer Revenue Market Share by Countries (2013-2018)
Figure North America Lung Cancer Revenue Market Share by Countries in 2017
Figure USA Lung Cancer Revenue and Growth Rate (2013-2018)
Figure Canada Lung Cancer Revenue and Growth Rate (2013-2018)
Figure Mexico Lung Cancer Revenue and Growth Rate (2013-2018)
Table Europe Lung Cancer Revenue (Million USD) by Countries (2013-2018)
Figure Europe Lung Cancer Revenue Market Share by Countries (2013-2018)
Figure Europe Lung Cancer Revenue Market Share by Countries in 2017
Figure Germany Lung Cancer Revenue and Growth Rate (2013-2018)
Figure UK Lung Cancer Revenue and Growth Rate (2013-2018)
Figure France Lung Cancer Revenue and Growth Rate (2013-2018)
Figure Russia Lung Cancer Revenue and Growth Rate (2013-2018)
Figure Italy Lung Cancer Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Lung Cancer Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Lung Cancer Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Lung Cancer Revenue Market Share by Countries in 2017
Figure China Lung Cancer Revenue and Growth Rate (2013-2018)
Figure Japan Lung Cancer Revenue and Growth Rate (2013-2018)
Figure Korea Lung Cancer Revenue and Growth Rate (2013-2018)
Figure India Lung Cancer Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Lung Cancer Revenue and Growth Rate (2013-2018)
Table South America Lung Cancer Revenue by Countries (2013-2018)
Table South America Lung Cancer Revenue Market Share by Countries (2013-2018)
Figure South America Lung Cancer Revenue Market Share by Countries (2013-2018)
Figure South America Lung Cancer Revenue Market Share by Countries in 2017
Figure Brazil Lung Cancer Revenue and Growth Rate (2013-2018)
Figure Argentina Lung Cancer Revenue and Growth Rate (2013-2018)
Figure Colombia Lung Cancer Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Lung Cancer Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Lung Cancer Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Lung Cancer Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Lung Cancer Revenue Market Share by Countries in 2017
Figure Saudi Arabia Lung Cancer Revenue and Growth Rate (2013-2018)
Figure UAE Lung Cancer Revenue and Growth Rate (2013-2018)
Figure Egypt Lung Cancer Revenue and Growth Rate (2013-2018)
Figure Nigeria Lung Cancer Revenue and Growth Rate (2013-2018)
Figure South Africa Lung Cancer Revenue and Growth Rate (2013-2018)
Table Global Lung Cancer Revenue (Million USD) by Type (2013-2018)
Table Global Lung Cancer Revenue Share by Type (2013-2018)
Figure Global Lung Cancer Revenue Share by Type (2013-2018)
Figure Global Lung Cancer Revenue Share by Type in 2017
Table Global Lung Cancer Revenue Forecast by Type (2018-2023)
Figure Global Lung Cancer Market Share Forecast by Type (2018-2023)
Figure Global SCLC Lung Cancer? Revenue Growth Rate (2013-2018)
Figure Global NSCLC Lung Cancer Revenue Growth Rate (2013-2018)
Table Global Lung Cancer Revenue by Application (2013-2018)
Table Global Lung Cancer Revenue Share by Application (2013-2018)
Figure Global Lung Cancer Revenue Share by Application (2013-2018)
Figure Global Lung Cancer Revenue Share by Application in 2017
Table Global Lung Cancer Revenue Forecast by Application (2018-2023)
Figure Global Lung Cancer Market Share Forecast by Application (2018-2023)
Figure Global Hospital & Clinics Revenue Growth Rate (2013-2018)
Figure Global Cancer Research Centers Revenue Growth Rate (2013-2018)
Figure Global Laboratories Revenue Growth Rate (2013-2018)
Figure Global Lung Cancer Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Lung Cancer Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Lung Cancer Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Lung Cancer Revenue Market Forecast (2018-2023)
Figure Europe Lung Cancer Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Lung Cancer Revenue Market Forecast (2018-2023)
Figure South America Lung Cancer Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Lung Cancer Revenue Market Forecast (2018-2023)